| [1] |
梁晨, 唐神结, 林明贵. 结核病综合治疗研究进展. 结核与肺部疾病杂志, 2024, 5(1):70-80. doi:10.19983/j.issn.2096-8493.20230112.
|
| [2] |
World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
|
| [3] |
巩盼, 李星宇, 来坤, 等. 基于定量CT检测浸润性肺结核病变的可行性研究. 临床放射学杂志, 2024, 43(4): 567-573. doi:10.13437/j.cnki.jcr.2024.04.021.
|
| [4] |
中华人民共和国卫生部. WS 288—2008肺结核诊断标准. 2008-08-01.
|
| [5] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 结核与肺部疾病杂志, 2024, 5(4): 376-378. doi:10.19983/j.issn.2096-8493.2024022.
|
| [6] |
卫生部疾病预防控制局, 卫生部医政司, 中国疾病预防控制中心. 《中国结核病防治规划实施工作指南(2008年版)》. 北京: 中国协和医科大学出版社, 2009.
|
| [7] |
中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021.
|
| [8] |
陈丽燕, 张晓强, 余建平, 等. 2013—2022年杭州市临平区登记肺结核患者特点及治疗转归影响因素分析. 中国防痨杂志, 2024, 46(12):1459-1468. doi:10.19982/j.issn.1000-6621.20240326.
|
| [9] |
Nijiati M, Guo L, Abulizi A, et al. Deep learning and radiomics of longitudinal CT scans for early prediction of tuberculosis treatment outcomes. Eur J Radiology, 2023, 169:111180.doi:10.1016/j.ejrad.2023.111180.
|
| [10] |
薛玉, 杨新婷, 王桂荣, 等. 急诊肺结核患者死亡的危险因素及风险模型建立. 中国防痨杂志, 2025, 47(2): 189-194. doi:10.19982/j.issn.1000-6621.20240321.
|
| [11] |
Bankier AA, MacMahon H, Colby T, et al. Fleischner Society: Glossary of Terms for Thoracic Imaging. Radiology, 2024, 310(2): e232558. doi:10.1148/radiol.232558.
|
| [12] |
郑珊, 冯慧芬, 徐晶, 等. 手足口病患者外周血免疫细胞水平变化与重症程度关联的巢式病例对照研究. 中国免疫学杂志, 2025, 41(9): 2232-2236.
|
| [13] |
屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读. 结核与肺部疾病杂志, 2025, 6(6): 613-623. doi:10.19983/j.issn.2096-8493.20250178.
|
| [14] |
Kritski AL, Rodrigues de Jesus LS, Andrade MK, et al. Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes. Chest, 1997, 111(5): 1162-1167. doi:10.1378/chest.111.5.1162.
pmid: 9149564
|
| [15] |
Tweya H, Kanyerere H, Ben-Smith A, et al. Re-treatment tuberculosis cases categorised as “other”: are they properly managed?. PLoS One, 2011, 6(12): e28034. doi:10.1371/journal.pone.0028034.
|
| [16] |
Bhalla AS, Goyal A, Guleria R, et al. Chest tuberculosis: Radiological review and imaging recommendations. Indian J Radiol Imaging, 2015, 25(3): 213-225. doi:10.4103/0971-3026.161431.
|
| [17] |
Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings-early active disease and sequential change with antituberculous therapy. Radiology, 1993, 186(3): 653-660. doi:10.1148/radiology.186.3.8430169.
pmid: 8430169
|
| [18] |
Kligerman SJ, Franks TJ, Galvin JR. From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics, 2013, 33(7):1951-1975. doi:10.1148/rg.337130057.
pmid: 24224590
|
| [19] |
Fong I, Low TB, Yii A. Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study. Chron Respir Dis, 2022, 19: 14799731221098714. doi:10.1177/14799731221098714.
|
| [20] |
Seo W, Kim HW, Kim JS, et al. Long term management of people with post-tuberculosis lung disease. Korean J Intern Med, 2024, 39(1): 7-24. doi:10.3904/kjim.2023.395.
pmid: 38225822
|
| [21] |
Rozenshtein A, Hao F, Starc MT, et al. Radiographic appearance of pulmonary tuberculosis: dogma disproved. AJR Am J Roentgenol, 2015, 204(5): 974-978. doi:10.2214/AJR.14.13483.
|
| [22] |
Leung AN, Müller NL, Pineda PR, et al. Primary tuberculosis in childhood: radiographic manifestations. Radiology, 1992, 182(1): 87-91. doi:10.1148/radiology.182.1.1727316.
pmid: 1727316
|
| [23] |
Liu QX, Tang DY, Xiang X, et al. Associations between nutritional and immune status and clinicopathologic factors in patients with tuberculosis: A comprehensive analysis. Front Cell Infect Microbiol, 2022, 12: 1013751. doi:10.3389/fcimb.2022.1013751.
|
| [24] |
Cocchetto DM, Tschanz C, Bjornsson TD. Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Ther Drug Monit, 1983, 5(2): 161-168. doi:10.1097/00007691-198306000-00002.
pmid: 6879639
|
| [25] |
Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med, 2006, 174(8): 935-952. doi:10.1164/rccm.200510-1666ST.
|
| [26] |
Lee S, Yim JJ, Kwak N, et al. Deep Learning to Determine the Activity of Pulmonary Tuberculosis on Chest Radiographs. Radiology, 2021, 301(2): 435-442. doi:10.1148/radiol.2021210063.
|
| [27] |
Liao KM, Liu CF, Chen CJ, et al. Using an Artificial Intelligence Approach to Predict the Adverse Effects and Prognosis of Tuberculosis. Diagnostics (Basel), 2023, 13(6): 1075. doi:10.3390/diagnostics13061075.
|